FRANKFURT/NEW YORK, April 13 (Reuters) - Generic drug maker Mylan is in advanced discussions to acquire Merck KGaA’s consumer health unit after other bidders failed to meet the German company’s price expectations, people familiar with the matter said.
No comments:
Post a Comment